10 March 2021
Premier Miton Group plc
("Premier Miton" or the "Company")
Director/PDMR Shareholding
Premier Miton Group plc (AIM: PMI) announces that it has today granted nil cost contingent share rights (the 'Awards') over 3,680,000 ordinary shares of 0.02p each in the Company (the 'Shares') subject to certain retention and deferral arrangements to a number of employees and to two Persons Discharging Managerial Responsibilities ('PDMR'). The Awards will be satisfied from shares held by the Company's employee benefit trusts. Vesting of the Awards is subject to continued employment and malus and clawback provisions.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
| 1. | Details of PDMR / person closely associated with them ("PCA") | |||||
| a) | Name | Michael O'Shea | ||||
| 2. | Reason for the notification | |||||
| a) | Position / status | Director | ||||
| b) | Initial notification / amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Premier Miton Group plc | ||||
| b) | LEI | 213800LK2M4CLJ4H2V85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of financial instrument Identification Code | Ordinary Shares of 0.02p each in Premier Miton Group plc ISIN: GB00BZB2KR63
| ||||
| b) | Nature of the transaction | Grant of Award subject to deferral
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information Aggregated volume Price | N/A
| ||||
| e) | Date of the transaction | 10 March 2021
| ||||
| f) | Place of the transaction
| Outside a trading Venue
| ||||
| 1. | Details of PDMR / person closely associated with them ("PCA") | |||||
| a) | Name | Piers Harrison | ||||
| 2. | Reason for the notification | |||||
| a) | Position / status | Director | ||||
| b) | Initial notification / amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Premier Miton Group plc | ||||
| b) | LEI | 213800LK2M4CLJ4H2V85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of financial instrument Identification Code | Ordinary Shares of 0.02p each in Premier Miton Group plc ISIN: GB00BZB2KR63
| ||||
| b) | Nature of the transaction | Grant of Award subject to deferral
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information Aggregated volume Price | N/A
| ||||
| e) | Date of the transaction | 10 March 2021
| ||||
| f) | Place of the transaction
| Outside a trading Venue
| ||||
LEI Number: 213800LK2M4CLJ4H2V85
For further information, please contact:
| Premier Miton Group plc Mike O'Shea, Chief Executive Officer
|
01483 306 090
|
| Numis Securities Limited (NOMAD and Broker) Charles Farquhar / Kevin Cruickshank
|
020 7260 1000
|
| Liberum Capital Limited (Joint Broker) Richard Crawley / Jamie Richards
|
020 3100 2000 |
| Smithfield Consultants (Financial PR) John Kiely / Andrew Wilde / Imogen Gardam
|
020 3047 2544 / 07785 275665
|
Notes to editors:
Premier Miton Investors is focused on delivering good investment outcomes for investors through relevant products and active management across its range of investment strategies, which include equity, fixed income, multi-asset and absolute return.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
